Evidence map›Paper›PMID 40084394›Full record

ArticleBrain and behavior2025

Resveratrol Alleviates the Prenatally Intermittent Hypoxia-Induced Cognitive Impairment in Male Offspring Mice Through Modulating the SIRT1/HIF-1α Pathway.

Xun He, Ziwei Cao, Xinyi Chen, Jie Hu, Jiaxuan Li, Xinhui Jia, Juncang Wu, Xuechun Liu

Abstract read
In one paragraph

Article in Brain and behavior, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Review
  3. Food science & nutrition · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Xun HeDepartment of Neurology, Hefei Second People's Hospital Affiliated to Bengbu Medical University, Hefei, Anhui, China.
Ziwei CaoDepartment of Neurology, the Second People's Hospital of Hefei, Hefei, Anhui, China.
Xinyi ChenDepartment of Neurology, Hefei Hospital Affiliated to Anhui Medical University (the Second People's Hospital of Hefei), Hefei, Anhui, China.
Jie HuDepartment of Neurology, Hefei Hospital Affiliated to Anhui Medical University (the Second People's Hospital of Hefei), Hefei, Anhui, China.ORCID https://orcid.org/0009-0006-5445-3736
Jiaxuan LiDepartment of Neurology, Hefei Hospital Affiliated to Anhui Medical University (the Second People's Hospital of Hefei), Hefei, Anhui, China.
Xinhui JiaDepartment of Neurology, Hefei Hospital Affiliated to Anhui Medical University (the Second People's Hospital of Hefei), Hefei, Anhui, China.
Juncang WuDepartment of Neurology, Hefei Second People's Hospital Affiliated to Bengbu Medical University, Hefei, Anhui, China.
Xuechun LiuDepartment of Neurology, Hefei Second People's Hospital Affiliated to Bengbu Medical University, Hefei, Anhui, China.ORCID https://orcid.org/0009-0007-6417-1027

Funding

Bengbu Medical University Natural Science Key Project 2023byzd241Research Project of Anhui Medical University's Basic and Clinical Collaborative Research Enhancement Program 2023xkjT048
6 · The paper itself

Abstract

objectiveGrowing evidence indicate that prenatal intermittent hypoxia (PIH) exposure can have an impact on the critical brain nerve development of the fetus, resulting in cognitive deficits in the offspring mice. Resveratrol, recognized for its anti-inflammatory and antioxidant capabilities, has potential to ameliorate synaptic dysfunction, which in turn may contribute to its positive influence on cognitive impairment. Nevertheless, the precise manner in which resveratrol mitigates cognitive deficits stemming from maternal hypoxia remains to be fully elucidated, including the specific mechanisms at play.

methodPregnant C57BL/6J mice were exposed to intermittent hypoxia using the ProOx-100 animal hypoxia control system during late pregnancy for 7 consecutive days. Resveratrol treatment at 40 mg/kg dosage was given to the subjects between postnatal Days 60 and 88. Morris water maze test was utilized to assess the cognitive capabilities of the male offspring mice. ELISA was employed to measure the concentrations of pro-inflammatory cytokines within the hippocampal region of the mature offspring mice. The expression levels of the regulatory proteins SIRT1 and HIF-1α, along with the synaptic plasticity markers SYP, Arc, GAP-43, and PSD-95 were measured by employing western blotting and RT-qPCR.

resultsIn male offspring subjected to PIH, there was a marked decline in learning and memory capabilities, accompanied by increased levels of IL-1, IL-6, and TNF-α within the hippocampal region. Administration of resveratrol notably ameliorated the cognitive deficits observed in these offspring and mitigated the heightened levels of pro-inflammatory cytokines. Furthermore, exposure to PIH was associated with a reduction in the expression of key proteins such as SIRT1, HIF-1α, Arc, GAP-43, PSD-95, and SYP within the hippocampal region, which were subsequently normalized following resveratrol intervention.

conclusionThe findings from our study indicate that resveratrol potently alleviates learning and memory impairments, the inflammatory response, and impairments in synaptic plasticity, which are induced by maternal intermittent hypoxia, by modulating the SIRT1/HIF-1α signaling pathway.

Indexed as

Cognitive DysfunctionHypoxiaHypoxia-Inducible Factor 1, alpha SubunitPrenatal Exposure Delayed EffectsResveratrolSirtuin 1AnimalsFemaleHippocampusMaleMiceMice, Inbred C57BLNeuronal PlasticityPregnancySignal TransductionHif1a protein, mouseHypoxia-Inducible Factor 1, alpha SubunitResveratrolSirt1 protein, mouseSirtuin 1cognitive impairmentprenatal intermittent hypoxiaresveratrolSIRT1/HIF‐1α pathway

Identifiers

PMID40084394
PMCPMC11907201

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.